Clinical trials
Withdrawn Phase 2 Gliosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jonsson Comprehensive Cancer Center | 2 |
| Duke University | 1 |
| Lisata Therapeutics, Inc. | 1 |
| M.D. Anderson Cancer Center | 1 |
| NYU Langone Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 6 |
| Gliosarcoma | 6 |
| Central Nervous System Neoplasms | 4 |
| Oligodendroglioma | 3 |
| Astrocytoma | 2 |
| Brain Neoplasms | 1 |
| Ependymoma | 1 |
| Glioma | 1 |
| Glioma, Subependymal | 1 |
| Neuroectodermal Tumors, Primitive | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.